查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
到 2028 年凍乾注射劑市場預測-COVID-19 的影響以及按包裝類型、交付類型、適應症和最終用戶進行的全球分析
市場調查報告書
商品編碼
1126250

到 2028 年凍乾注射劑市場預測-COVID-19 的影響以及按包裝類型、交付類型、適應症和最終用戶進行的全球分析

Lyophilized Injectable Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type of Packaging, Type of Delivery, Indication, and End User
出版日期: | 出版商: The Insight Partners | 英文 200 Pages | 訂單完成後即時交付

價格

全球凍乾注射劑市場預計將從 2021 年的 27.1942 億美元增至 2028 年的 40.127 億美元，2022 年至 2028 年的複合年增長率為 5.8%。我來了。

對研究合同製造服務的需求不斷增加、藥物批准的增加以及對生物製劑的需求不斷增加，這些都在推動市場增長。然而，頻繁的產品召回是市場增長的障礙。

冷凍乾燥或冷凍乾燥是通過將冰晶昇華成水蒸氣來完成的。冷凍乾燥是一種基於負溫度、產品活性和穩定性的過程，可以限制產品損壞並保留活性成分，同時避免分子降解。因此，冷凍乾燥在製藥和診斷領域特別受歡迎。凍乾注射劑質量的提高和保質期的延長為製造商將凍乾工藝納入其產品製造創造了越來越多的機會。對合同製造和研究服務的需求很大，我們提供凍乾注射劑，為最終用戶提供優質產品。

此外，隨著許多製藥公司重新關注研發等核心能力，內部製造能力脫鉤，製造領域對合同研發服務 (CRAM) 的需求不斷增加。我來了。此外，CRAM 通過為製藥公司提供具有多站點供應策略和備份能力的額外站點，在減輕供應短缺風險方面發揮著關鍵作用。例如，2019 年，Samsung Biologics 與 GI Innovation 簽訂了免疫化療協議。根據該協議，Samsung Biologics 提供從細胞系開發到 I 期藥物製造的服務。

此外，凍乾注射劑所提供的優勢，例如安全運輸和延長藥物保質期，已導致全球許多公司採用凍乾技術。

多個市場都見證了 COVID-19 大流行的全球影響。由於嚴格的封鎖和旅行限制，臨床試驗已暫停。在醫療保健領域，重點主要轉向治療 COVID-19 患者和開發 COVID-19 疫苗。在大流行的早期階段，這些因素對市場增長產生了積極影響。

在 COVID-19 流行高峰期間，對瑞德西韋（一種用於治療患者的抗病毒藥物）的需求異常高。凍乾注射劑市場的製造商正在通過維持足夠的供應鏈來為未來做準備，以避免像 COVID-19 這樣的漏洞。包括Gilead Sciences在內的大型製藥公司已獲得美國 FDA 的緊急使用授權（EUA），用於使用瑞德西韋治療住院的 COVID-19 患者。此外，2020 年 5 月，Gilead Sciences將其自願、非獨家許可擴展到 Cipla 用於 CIPREMI，這是一種由 Cipla 生產和銷售的瑞德西韋仿製藥。為了應對動蕩的市場環境，公司正在利用 BFSI 行業提供的政府計劃和融資設施來提高運營效率。例如，2020 年 5 月，美國政府與一群美國仿製藥製造商達成了一項價值 8.12 億美元的協議，以在大流行期間增加該國的藥品供應。因此，由於 COVID-19 大流行導致對藥品的需求增加，加強了全球凍乾注射劑市場。

區域洞察

北美在全球凍乾注射劑市場中佔有最大份額，而亞太地區是增長最快的地區。由於對用於安全包裝和延長保質期的凍乾注射劑的需求增加，由於 COVID-19 大流行導致藥品產量增加，以及醫療保健行業的研發增加，預計北美市場將在預測期內增長。成長在

預計 2022 年至 2028 年間，亞太地區的全球凍乾注射劑市場的複合年增長率最高。預計該地區的市場在未來幾年將顯著增長，包括中國、印度和日本在內的國家。由於生物技術、製藥和生物製藥公司增加投資以及凍乾注射劑在各個領域的使用增加，研發活動增加，正在推動亞太地區對凍乾注射劑的需求。

基於包裝類型的見解

根據包裝類型，全球凍乾注射劑市場分為一次性小瓶、即時重建和特殊包裝。到 2021 年，一次性小瓶細分市場將佔據最大的市場份額，而特種包裝細分市場預計在預測期內的複合年增長率最高，為 6.7%。

基於貨件類型的見解

根據交付類型，全球凍乾注射劑市場細分為預填充稀釋劑注射器、專有重組裝置、單步裝置和多步裝置。預填充稀釋劑注射器部分將在 2021 年佔據最大的市場份額，預計在預測期內的複合年增長率最高，為 6.3%。

基於指示的洞察

根據適應症，全球凍乾注射劑市場細分為代謝和腫瘤疾病、傳染病、自身免疫性疾病和其他適應症。代謝和腫瘤學部分預計將在 2021 年佔據最大的市場份額，在預測期內實現 6.2% 的最高複合年增長率。

最終用戶群洞察

根據最終用戶，全球凍乾注射劑市場細分為醫院、門診手術中心、專科診所等。 2021年，醫院板塊佔據了最大的市場份額。然而，預計專科診所部門在預測期內的市場複合年增長率最高，為 6.3%。

世界衛生組織 (WHO)、Globocan、世界銀行數據、國家衛生服務 (NHS)、國家醫學圖書館 (NLM)、醫療器械促進協會

內容

第一章介紹

  • 調查範圍
  • Insight Partners 研究報告指南
  • 市場細分
    • 全球凍乾注射劑市場-按包裝類型
    • 全球凍乾注射劑市場：按劑量類型
    • 全球凍乾注射劑市場 - 按適應症
    • 全球凍乾注射劑市場：按最終用戶分類
    • 全球凍乾注射劑市場 - 按地區

第 2 章凍乾注射劑市場 - 要點

第三章研究方法

  • 調查目標
  • 二次調查
  • 初步調查

第 4 章凍乾注射劑市場 - 市場情況

  • PEST 分析
    • 北美 PEST 分析
    • 歐洲 PEST 分析
    • 亞太地區的 PEST 分析
    • 中東和非洲 PEST 分析
    • 拉丁美洲 PEST 分析
  • 專家意見

第 5 章凍乾注射劑市場 - 主要市場動態

  • 市場驅動力
    • 對研發合同製造服務的需求增加
    • 藥物批准數量增加
    • 對生物製品的需求增加
  • 市場製約因素
    • 產品召回
  • 市場機會
    • 凍乾注射管線擴建
  • 未來趨勢
    • 凍乾包裝的創新
  • 影響分析

第 6 章凍乾注射劑市場：全球分析

  • 全球凍乾注射劑市場：收入、預測和分析
    • 全球凍乾注射劑市場：收入預測與分析
    • 凍乾注射劑市場：潛力分析（按地區）
  • 比較公司分析
  • 增長策略分析
  • 凍乾注射劑市場主要公司市場分析
  • 主要公司的業績
      • Baxter International
      • Nipro
  • 市場份額分析
  • 冷凍乾燥產品 (ASP) 前 3 名（2021 年）

第 7 章：凍乾注射劑市場分析 - 按包裝形式

  • 按包裝類型劃分的凍乾注射劑市場收入份額（2021 年、2028 年）
  • 一次性小瓶
  • 護理點建設
  • 特殊包裝

第 8 章凍乾注射劑市場分析 - 按交付類型

  • 按交付類型分列的凍乾注射劑市場收入份額（2021 年、2028 年）
  • 預裝稀釋劑注射器
  • 單步裝置
  • 自有重建設備
  • 多步裝置

第 9 章凍乾注射劑市場分析 - 按適應症

  • 按適應症分列的凍乾注射劑市場收入份額（2021 年、2028 年）
  • 代謝和腫瘤性疾病
  • 感染
  • 自身免疫性疾病
  • 其他適應症

第 10 章凍乾注射劑市場 - 按最終用戶分類

  • 凍乾注射劑市場：按最終用戶分類，2021 年、2028 年（%）
  • 醫院
  • 門診手術中心
  • 專科診所
  • 其他最終用戶

第 11 章凍乾注射劑市場收入和到 2028 年的預測-區域分析

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
    • 其他歐洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳大利亞
    • 其他亞太地區
  • 中美洲和南美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲
  • 中東和非洲
    • 中東和非洲
      • 南非
      • 沙特阿拉伯
      • 阿聯酋
      • 其他中東

第 12 章 COVID-19 大流行對全球凍乾注射劑市場的影響

  • 北美
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東和非洲

第 13 章凍乾注射劑市場 - 行業格局

  • 凍乾注射劑市場的增長戰略
  • 無機增長戰略
  • 有機增長戰略

第 14 章公司簡介

  • Baxter
  • Nipro
  • Curia Global, Inc.
  • Recipharm AB
  • Vetter Pharma
  • Jubilant HollisterStier（Jubilant Pharma Limited）
  • Aristopharma Ltd.
  • CordenPharma International
  • Credence MedSystems, Inc.
  • S.G. Biopharm Pvt. Ltd.

第十五章附錄

  • 關於 The Insight Partners
  • 詞彙表
Product Code: TIPRE00004411

The global lyophilized injectable market is projected to reach US$ 4,001.27 million by 2028 from US$ 2,719.42 million in 2021; it is expected to grow at a CAGR of 5.8% from 2022 to 2028.

The increasing demand for contract research manufacturing services, rising approvals of pharmaceuticals, and growing demand for biologics drive the growth of the market. However, high product recalls hamper the market growth.

Freeze drying, or lyophilization, consists of the sublimation of ice crystals into vapor. Lyophilization is a process based on negative temperatures, the product's activity, and stability, along with active ingredients that are retained while limiting any damage to the product and avoiding any degradation of the molecules. Thus, freeze-drying is especially popular in the pharmaceutical & diagnostic sectors. The increased quality and extended shelf life of lyophilized injectable drugs created growth opportunities for manufacturers to implement the lyophilization process in product manufacturing. The contract manufacturing and research services are in huge demand, delivering lyophilized injectable drugs to offer high-quality products to the end users.

Moreover, many pharmaceutical companies are refocusing on their core capabilities, such as research and development, leading to divestments of in-house manufacturing capacities, which is propelling the demand for contract research manufacturing services (CRAMs) for manufacturing. Furthermore, CRAMs play crucial roles to mitigate the risk of supply shortages by offering additional sites for pharmaceutical companies with multisite supply strategies and backup capacities. For instance, in 2019, Samsung Biologics and GI Innovation signed a contract for immunochemotherapy. Under the agreement, Samsung Biologics provided services ranging from the development of cell line to the production of Phase I drug substances.

Furthermore, the advantages offered by the lyophilized injectables, such as safe transit and extended pharmaceutical storage life, increased the adoption of the lyophilization technique by many enterprises globally.

The global impacts of COVID-19 pandemic are witnessed across several markets. Due to stringent lockdown and movement restrictions, clinical trials were temporarily halted. In the healthcare sector, the focus was shifted primarily to the treatment of COVID-19 patients and the development of the COVID-19 vaccine. All these factors had a positive impact on market growth in the initial phase of pandemic.

There was an unusual demand for Remdesivir, an antiviral medicine used to treat patients, during the peak of the COVID-19 outbreak. Manufacturers in the lyophilized injectables market are preparing for the future by keeping adequate supply chains to avoid any COVID-19-like vulnerabilities. Gilead Sciences and other big pharma companies received an Emergency Use Authorization (EUA) by the US FDA for the use of remdesivir for the treatment of hospitalized COVID-19 patients. Further, in May 2020, Gilead Sciences Inc. extended a voluntary nonexclusive license to Cipla to manufacture and market Cipla's generic version of remdesivir called CIPREMI. Companies are utilizing government programs and financing schemes given by the BFSI industry to streamline their operations in response to turbulent market conditions. For instance, in May 2020, the US government entered an agreement with a group of American generic medicine manufacturers potentially worth US$ 812 million to bolster the country's drug supply amid the pandemic. Thus, the growing demand for drugs due to the COVID-19 pandemic bolstered the global lyophilized injectable market.

Geography-Based Insights

North America holds the largest share of the global lyophilized injectable market, whereas Asia Pacific is the fastest-growing region. The market in North America is expected to grow during the forecast period owing to the increasing demand for lyophilized injectables for safe packaging and prolonged shelf life, growing pharmaceutical production due to the COVID-19 pandemic, and rising research and development in the healthcare industry.

During 2022-2028, Asia Pacific is likely to register the highest CAGR in the global lyophilized injectable market. The market in the region is expected to grow significantly in countries, including China, India, and Japan, in the coming years. The growing research & development activities due to the increase in the investments by biotechnology, pharmaceutical, and biopharmaceutical companies and rising applications of lyophilized injectable drug in various fields are among the factors propelling the demand for lyophilized injectables in Asia Pacific.

Type of Packaging- Based Insights

The global lyophilized injectable market, based on type of packaging, is segmented into single-use vials, point-of-care reconstitution, and specialty packaging. In 2021, the single-use vials segment accounted for the largest market share, whereas the specialty packaging segment is expected to register the highest CAGR of 6.7% during the forecast period.

Type of Delivery- Based Insights

Based on type of delivery, the global lyophilized injectable market is segmented into prefilled diluent syringes, proprietary reconstitution devices, single-step devices, and multi-step devices. The prefilled diluent syringes segment held the largest market share in 2021 and is anticipated to register the highest CAGR of 6.3% during the forecast period.

Indication- Based Insights

Based on indication, the global lyophilized injectable market is segmented into metabolic and oncology conditions, infectious diseases, autoimmune diseases, and other indications. The metabolic and oncology conditions segment held the largest market share in 2021 and is anticipated to register the highest CAGR of 6.2% during the forecast period.

End User- Based Insights

Based on end user, the global lyophilized injectable market is segmented into hospitals, ambulatory surgical centers, specialty clinics, and others. The hospitals segment held the largest market share in 2021. However, the specialty clinics segment is estimated to register the highest CAGR of 6.3% in the market during the forecast period.

The World Health Organization (WHO), Globocan, World Bank Data, National Health Service (NHS), National Library of Medicine (NLM), and Association for the Advancement of Medical Instrumentation are a few secondary sources referred to while preparing the report on the global lyophilized injectable market.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the lyophilized injectable market.

Highlights key business priorities in order to assist companies to realign their business strategies.

The key findings and recommendations highlight crucial progressive industry trends in the lyophilized injectable market, thereby allowing players across the value chain to develop effective long-term strategies.

Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

Enhancing the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Global Lyophilized Injectable Market - By Type of Packaging
    • 1.3.2 Global Lyophilized Injectable Market - By Type of Delivery
    • 1.3.3 Global Lyophilized Injectable Market - By Indication
    • 1.3.4 Global Lyophilized Injectable Market - By End User
    • 1.3.5 Global Lyophilized Injectable Market - By Geography

2. Lyophilized Injectable Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Lyophilized Injectable Market - Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 North America PEST Analysis
    • 4.2.2 Europe PEST Analysis
    • 4.2.3 Asia Pacific PEST Analysis
    • 4.2.4 Middle East and Africa PEST Analysis
    • 4.2.5 South and Central America PEST Analysis
  • 4.3 Experts Opinion

5. Lyophilized Injectable Market- Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Increasing Demand for Contract Research Manufacturing Services
    • 5.1.2 Rising Approvals of Pharmaceuticals
    • 5.1.3 Increasing Demand of Biologics
  • 5.2 Market Restraints
    • 5.2.1 Product Recalls
  • 5.3 Market Opportunities
    • 5.3.1 Expansion of Pipeline of Lyophilized Injectable Drugs
  • 5.4 Future Trends
    • 5.4.1 Advancement in Lyophilized Packaging
  • 5.5 Impact Analysis

6. Lyophilized Injectable Market- Global Analysis

  • 6.1 Global Lyophilized Injectable Market Revenue Forecast And Analysis
    • 6.1.1 Global Lyophilized Injectable Market Revenue Forecast And Analysis
    • 6.1.2 Global Lyophilized Injectable Market - Market Potential Analysis, by Region
  • 6.2 Comparative Company Analysis
  • 6.3 Growth Strategy Analysis
  • 6.4 Market Positioning Analysis of Key Players in Lyophilized Injectable Market
  • 6.5 Performance of Key Players
      • 6.5.1.1 Baxter International
      • 6.5.1.2 Nipro
  • 6.6 Market Share Analysis
  • 6.7 Top 3 Lyophilized Drug Products (ASP) (2021)

7. Lyophilized Injectable Market Analysis - By Type of Packaging

  • 7.1 Overview
  • 7.2 Lyophilized Injectable Market Revenue Share, by Type of Packaging (2021 and 2028)
  • 7.3 Single-use vials
    • 7.3.1 Overview
    • 7.3.2 Single-use vials: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.4 Point-of-Care Reconstitution
    • 7.4.1 Overview
    • 7.4.2 Point-of-Care Reconstitution: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.5 Specialty Packaging
    • 7.5.1 Overview
    • 7.5.2 Specialty Packaging: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)

8. Lyophilized Injectable Market Analysis - By Type Of Delivery

  • 8.1 Overview
  • 8.2 Lyophilized Injectable Market Revenue Share, by Type of Delivery (2021 and 2028)
  • 8.3 Prefilled Diluent Syringes
    • 8.3.1 Overview
    • 8.3.2 Prefilled Diluent Syringes: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
  • 8.4 Single Step Devices
    • 8.4.1 Overview
    • 8.4.2 Single Step Devices: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
  • 8.5 Proprietary Reconstitution Devices
    • 8.5.1 Overview
    • 8.5.2 Proprietary Reconstitution Devices: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
  • 8.6 Multi-Step Devices
    • 8.6.1 Overview
    • 8.6.2 Multi-Step Devices: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)

9. Lyophilized Injectable Market Analysis - By Indication

  • 9.1 Overview
  • 9.2 Lyophilized Injectable Market Revenue Share, by Indication (2021 and 2028)
  • 9.3 Metabolic and Oncology Conditions
    • 9.3.1 Overview
    • 9.3.2 Metabolic and Oncology Conditions: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
  • 9.4 Infectious Diseases
    • 9.4.1 Overview
    • 9.4.2 Infectious Diseases: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
  • 9.5 Autoimmune Diseases
    • 9.5.1 Overview
    • 9.5.2 Autoimmune Diseases: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
  • 9.6 Other Indications
    • 9.6.1 Overview
    • 9.6.2 Other Indications: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)

10. Lyophilized Injectable Market -By End User

  • 10.1 Overview
  • 10.2 Lyophilized Injectable Market, by End User, 2021 and 2028 (%)
  • 10.3 Hospitals
    • 10.3.1 Overview
    • 10.3.2 Hospitals: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
  • 10.4 Ambulatory Surgical Centers
    • 10.4.1 Overview
    • 10.4.2 Ambulatory Surgical Centers: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
  • 10.5 Specialty Clinics
    • 10.5.1 Overview
    • 10.5.2 Specialty Clinics: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
  • 10.6 Other End Users
    • 10.6.1 Overview
    • 10.6.2 Other End Users: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)

11. Lyophilized Injectable Market Revenue and Forecasts to 2028 - Geographical Analysis

  • 11.1 North America: Lyophilized Injectable Market
    • 11.1.1 Overview
    • 11.1.2 North America: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
    • 11.1.3 North America: Lyophilized Injectable Market, by Type of Packaging, 2019-2028 (US$ Million)
    • 11.1.4 North America: Lyophilized Injectable Market, by Type of Delivery, 2019-2028 (US$ Million)
    • 11.1.5 North America: Lyophilized Injectable Market, by Indication, 2019-2028 (US$ Million)
    • 11.1.6 North America: Lyophilized Injectable Market, by End User, 2019-2028 (US$ Million)
    • 11.1.7 North America: Lyophilized Injectable Market, by Country, 2021 & 2028 (%)
      • 11.1.7.1 US: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
        • 11.1.7.1.1 Overview
        • 11.1.7.1.2 US: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
        • 11.1.7.1.3 US: Lyophilized Injectable Market, by Type of Packaging, 2019-2028 (US$ Million)
        • 11.1.7.1.4 US: Lyophilized Injectable Market, by Type of Delivery, 2019-2028 (US$ Million)
        • 11.1.7.1.5 US: Lyophilized Injectable Market, by Indication, 2019-2028 (US$ Million)
        • 11.1.7.1.6 US: Lyophilized Injectable Market, by End User, 2019-2028 (US$ Million)
      • 11.1.7.2 Canada: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
        • 11.1.7.2.1 Overview
        • 11.1.7.2.2 Canada: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
        • 11.1.7.2.3 Canada: Lyophilized Injectable Market, by Type of Packaging, 2019-2028 (US$ Million)
        • 11.1.7.2.4 Canada: Lyophilized Injectable Market, by Type of Delivery, 2019-2028 (US$ Million)
        • 11.1.7.2.5 Canada: Lyophilized Injectable Market, by Indication, 2019-2028 (US$ Million)
        • 11.1.7.2.6 Canada: Lyophilized Injectable Market, by End User, 2019-2028 (US$ Million)
      • 11.1.7.3 Mexico: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
        • 11.1.7.3.1 Overview
        • 11.1.7.3.2 Mexico: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
        • 11.1.7.3.3 Mexico: Lyophilized Injectable Market, by Type of Packaging, 2019-2028 (US$ Million)
        • 11.1.7.3.4 Mexico: Lyophilized Injectable Market, by Type of Delivery, 2019-2028 (US$ Million)
        • 11.1.7.3.5 Mexico: Lyophilized Injectable Market, by Indication, 2019-2028 (US$ Million)
        • 11.1.7.3.6 Mexico: Lyophilized Injectable Market, by End User, 2019-2028 (US$ Million)
  • 11.2 Europe: Lyophilized Injectable Market
    • 11.2.1 Overview
    • 11.2.2 Europe: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ 'Million)
    • 11.2.3 Europe: Lyophilized Injectable Market, by Type of Packaging, 2019-2028 (US$ 'Million)
    • 11.2.4 Europe: Lyophilized Injectable Market, by Type of Delivery, 2019-2028 (US$ 'Million)
    • 11.2.5 Europe: Lyophilized Injectable Market, by Indication, 2019-2028 (US$ 'Million)
    • 11.2.6 Europe: Lyophilized Injectable Market, by End User, 2019-2028 (US$ 'Million)
    • 11.2.7 Europe: Lyophilized Injectable Market, by Country, 2021 & 2028 (%)
      • 11.2.7.1 Germany: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ 'Million)
        • 11.2.7.1.1 Overview
        • 11.2.7.1.1 Germany: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ 'Million)
        • 11.2.7.1.2 Germany: Lyophilized Injectable Market, by Type of Packaging, 2019-2028 (US$ 'Million)
        • 11.2.7.1.3 Germany: Lyophilized Injectable Market, by Type of Delivery, 2019-2028 (US$ 'Million)
        • 11.2.7.1.4 Germany: Lyophilized Injectable Market, by Indication, 2019-2028 (US$ 'Million)
        • 11.2.7.1.5 Germany: Lyophilized Injectable Market, by End User, 2019-2028 (US$ 'Million)
      • 11.2.7.2 UK: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ 'Million)
        • 11.2.7.2.1 Overview
        • 11.2.7.2.2 UK: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ 'Million)
        • 11.2.7.2.3 UK: Lyophilized Injectable Market, by Type of Packaging, 2019-2028 (US$ 'Million)
        • 11.2.7.2.4 UK: Lyophilized Injectable Market, by Type of Delivery, 2019-2028 (US$ 'Million)
        • 11.2.7.2.5 UK: Lyophilized Injectable Market, by Indication, 2019-2028 (US$ 'Million)
        • 11.2.7.2.6 UK: Lyophilized Injectable Market, by End User, 2019-2028 (US$ 'Million)
      • 11.2.7.3 France: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ 'Million)
        • 11.2.7.3.1 Overview
        • 11.2.7.3.2 France: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ 'Million)
        • 11.2.7.3.3 France: Lyophilized Injectable Market, by Type of Packaging, 2019-2028 (US$ 'Million)
        • 11.2.7.3.4 France: Lyophilized Injectable Market, by Type of Delivery, 2019-2028 (US$ 'Million)
        • 11.2.7.3.5 France: Lyophilized Injectable Market, by Indication, 2019-2028 (US$ 'Million)
        • 11.2.7.3.6 France: Lyophilized Injectable Market, by End User, 2019-2028 (US$ 'Million)
      • 11.2.7.4 Italy: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ 'Million)
        • 11.2.7.4.1 Overview
        • 11.2.7.4.2 Italy: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ 'Million)
        • 11.2.7.4.3 Italy: Lyophilized Injectable Market, by Type of Packaging, 2019-2028 (US$ 'Million)
        • 11.2.7.4.4 Italy: Lyophilized Injectable Market, by Type of Delivery, 2019-2028 (US$ 'Million)
        • 11.2.7.4.5 Italy: Lyophilized Injectable Market, by Indication, 2019-2028 (US$ 'Million)
        • 11.2.7.4.6 Italy: Lyophilized Injectable Market, by End User, 2019-2028 (US$ 'Million)
      • 11.2.7.5 Spain: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ 'Million)
        • 11.2.7.5.1 Overview
        • 11.2.7.5.2 Spain: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ 'Million)
        • 11.2.7.5.3 Spain: Lyophilized Injectable Market, by Type of Packaging, 2019-2028 (US$ 'Million)
        • 11.2.7.5.4 Spain: Lyophilized Injectable Market, by Type of Delivery, 2019-2028 (US$ 'Million)
        • 11.2.7.5.5 Spain: Lyophilized Injectable Market, by Indication, 2019-2028 (US$ 'Million)
        • 11.2.7.5.6 Spain: Lyophilized Injectable Market, by End User, 2019-2028 (US$ 'Million)
      • 11.2.7.6 Rest of Europe: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ 'Million)
        • 11.2.7.6.1 Overview
        • 11.2.7.6.2 Rest of Europe: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ 'Million)
        • 11.2.7.6.3 Rest of Europe: Lyophilized Injectable Market, by Type of Packaging, 2019-2028 (US$ 'Million)
        • 11.2.7.6.4 Rest of Europe: Lyophilized Injectable Market, by Type of Delivery, 2019-2028 (US$ 'Million)
        • 11.2.7.6.5 Rest of Europe: Lyophilized Injectable Market, by Indication, 2019-2028 (US$ 'Million)
        • 11.2.7.6.6 Rest of Europe: Lyophilized Injectable Market, by End User, 2019-2028 (US$ 'Million)
  • 11.3 Asia Pacific Lyophilized Injectable Market Revenue and Forecasts To 2028
    • 11.3.1 Overview
    • 11.3.2 Asia Pacific Lyophilized Injectable Market Revenue and Forecasts to 2028 (US$ Million)
    • 11.3.3 Asia Pacific: Lyophilized Injectable Market Revenue and Forecasts to 2028, By Type of Packaging (US$ Million)
    • 11.3.4 Asia Pacific: Lyophilized Injectable Market, by Type of Delivery, 2019-2028 (US$ Million)
    • 11.3.5 Asia Pacific: Lyophilized Injectable Market, by Indication, 2019-2028 (US$ Million)
    • 11.3.6 Asia Pacific: Lyophilized Injectable Market, by End User, 2019-2028 (US$ Million)
    • 11.3.7 Asia Pacific: Lyophilized Injectable Market, by Country, 2021 & 2028 (%)
      • 11.3.7.1 China: Lyophilized Injectable Market Revenue and Forecasts to 2028 (US$ Million)
        • 11.3.7.1.1 Overview
        • 11.3.7.1.2 China: Lyophilized Injectable Market Revenue and Forecasts to 2028 (US$ Million)
        • 11.3.7.1.3 China: Lyophilized Injectable Market Revenue and Forecasts to 2028, By Type of Packaging (US$ Million)
        • 11.3.7.1.4 China: Lyophilized Injectable Market, by Type of Delivery, 2019-2028 (US$ Million)
        • 11.3.7.1.5 China: Lyophilized Injectable Market, by Indication, 2019-2028 (US$ Million)
        • 11.3.7.1.6 China: Lyophilized Injectable Market, by End User, 2019-2028 (US$ Million)
      • 11.3.7.2 India Lyophilized Injectable Market Revenue and Forecasts to 2028 (US$ Million)
        • 11.3.7.2.1 Overview
        • 11.3.7.2.2 India: Lyophilized Injectable Market Revenue and Forecasts to 2028 (US$ Million)
        • 11.3.7.2.3 India: Lyophilized Injectable Market Revenue and Forecasts to 2028, By Type of Packaging (US$ Million)
        • 11.3.7.2.4 India: Lyophilized Injectable Market, by Type of Delivery, 2019-2028 (US$ Million)
        • 11.3.7.2.5 India: Lyophilized Injectable Market, by Indication, 2019-2028 (US$ Million)
        • 11.3.7.2.6 India: Lyophilized Injectable Market, by End User, 2019-2028 (US$ Million)
      • 11.3.7.3 Japan: Lyophilized Injectable Market Revenue and Forecasts to 2028 (US$ Million)
        • 11.3.7.3.1 Overview
        • 11.3.7.3.2 Japan: Lyophilized Injectable Market Revenue and Forecasts to 2028 (US$ Million)
        • 11.3.7.3.3 Japan: Lyophilized Injectable Market Revenue and Forecasts to 2028, By Type of Packaging (US$ Million)
        • 11.3.7.3.4 Japan: Lyophilized Injectable Market, by Type of Delivery, 2019-2028 (US$ Million)
        • 11.3.7.3.5 Japan: Lyophilized Injectable Market, by Indication, 2019-2028 (US$ Million)
        • 11.3.7.3.6 Japan: Lyophilized Injectable Market, by End User, 2019-2028 (US$ Million)
      • 11.3.7.4 South Korea: Lyophilized Injectable Market Revenue and Forecasts to 2028 (US$ Million)
        • 11.3.7.4.1 Overview
        • 11.3.7.4.2 South Korea: Lyophilized Injectable Market Revenue and Forecasts to 2028 (US$ Million)
        • 11.3.7.4.3 South Korea: Lyophilized Injectable Market Revenue and Forecasts to 2028, By Type of Packaging (US$ Million)
        • 11.3.7.4.4 South Korea: Lyophilized Injectable Market, by Type of Delivery, 2019-2028 (US$ Million)
        • 11.3.7.4.5 South Korea: Lyophilized Injectable Market, by Indication, 2019-2028 (US$ Million)
        • 11.3.7.4.6 South Korea: Lyophilized Injectable Market, by End User, 2019-2028 (US$ Million)
      • 11.3.7.5 Australia: Lyophilized Injectable Market Revenue and Forecasts to 2028 (US$ Million)
        • 11.3.7.5.1 Overview
        • 11.3.7.5.2 Australia: Lyophilized Injectable Market Revenue and Forecasts to 2028 (US$ Million)
        • 11.3.7.5.3 Australia: Lyophilized Injectable Market Revenue and Forecasts to 2028, By Type of Packaging (US$ Million)
        • 11.3.7.5.4 Australia: Lyophilized Injectable Market, by Type of Delivery, 2019-2028 (US$ Million)
        • 11.3.7.5.5 Australia: Lyophilized Injectable Market, by Indication, 2019-2028 (US$ Million)
        • 11.3.7.5.6 Australia: Lyophilized Injectable Market, by End User, 2019-2028 (US$ Million)
      • 11.3.7.6 Rest of Asia Pacific: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
        • 11.3.7.6.1 Overview
        • 11.3.7.6.2 Rest of Asia Pacific: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
        • 11.3.7.6.3 Rest of Asia Pacific: Lyophilized Injectable Market Revenue and Forecasts to 2028, By Type of Packaging (US$ Million)
        • 11.3.7.6.4 Rest of Asia Pacific: Lyophilized Injectable Market, by Type of Delivery, 2019-2028 (US$ Million)
        • 11.3.7.6.5 Rest of Asia Pacific: Lyophilized Injectable Market, by Indication, 2019-2028 (US$ Million)
        • 11.3.7.6.6 Rest of Asia Pacific: Lyophilized Injectable Market, by End User, 2019-2028 (US$ Million)
  • 11.4 South and Central America Lyophilized Injectable Market
    • 11.4.1 Overview
    • 11.4.2 South and Central America Lyophilized Injectable Market Revenue and Forecast to 2028 (US$ Million)
    • 11.4.3 South and Central America: Lyophilized Injectable Market Revenue and Forecast to 2028, by Type of Packaging (US$ Million)
    • 11.4.4 South and Central America: Lyophilized Injectable Market Revenue and Forecast to 2028, by Type of Delivery (US$ Million)
    • 11.4.5 South and Central America: Lyophilized Injectable Market Revenue and Forecast to 2028, by Indication (US$ Million)
    • 11.4.6 South and Central America: Lyophilized Injectable Market Revenue and Forecast to 2028, by End User (US$ Million)
    • 11.4.7 South and Central America: Lyophilized Injectable Market, by Country, 2021 & 2028 (%)
      • 11.4.7.1 Brazil: Lyophilized Injectable Market - Revenue and Forecast to 2028 (USD Million)
        • 11.4.7.1.1 Overview
        • 11.4.7.1.2 Brazil Lyophilized Injectable Market Revenue and Forecast to 2028 (US$ Million)
        • 11.4.7.1.3 Brazil: Lyophilized Injectable Market Revenue and Forecast to 2028, By Type of Packaging (US$ Million)
        • 11.4.7.1.4 Brazil: Lyophilized Injectable Market Revenue and Forecast To 2028, By Type of Delivery (US$ Million)
        • 11.4.7.1.5 Brazil: Lyophilized Injectable Market Revenue and Forecast to 2028, By Indication (US$ Million)
        • 11.4.7.1.6 Brazil: Lyophilized Injectable Market Revenue and Forecast To 2028, By End User (US$ Million)
      • 11.4.7.2 Argentina: Lyophilized Injectable Market - Revenue and Forecast to 2028 (USD Million)
        • 11.4.7.2.1 Overview
        • 11.4.7.2.2 Argentina Lyophilized Injectable Market Revenue and Forecast to 2028 (US$ Million)
        • 11.4.7.2.3 Argentina: Lyophilized Injectable Market Revenue and Forecast to 2028, By Type of Packaging (US$ Million)
        • 11.4.7.2.4 Argentina: Lyophilized Injectable Market Revenue and Forecast To 2028, By Type of Delivery (US$ Million)
        • 11.4.7.2.5 Argentina: Lyophilized Injectable Market Revenue and Forecast to 2028, By Indication (US$ Million)
        • 11.4.7.2.6 Argentina: Lyophilized Injectable Market Revenue and Forecast To 2028, By End User (US$ Million)
      • 11.4.7.3 Rest of the South and Central America: Lyophilized Injectable Market - Revenue and Forecast to 2028 (USD Million)
        • 11.4.7.3.1 Overview
        • 11.4.7.3.2 Rest of the South and Central America Lyophilized Injectable Market Revenue and Forecast to 2028 (US$ Million)
        • 11.4.7.3.3 Rest of the South and Central America: Lyophilized Injectable Market Revenue and Forecast to 2028, By Type of Packaging (US$ Million)
        • 11.4.7.3.4 Rest of the South and Central America: Lyophilized Injectable Market Revenue and Forecast To 2028, By Type of Delivery (US$ Million)
        • 11.4.7.3.5 Rest of the South and Central America: Lyophilized Injectable Market Revenue and Forecast to 2028, By Indication (US$ Million)
        • 11.4.7.3.6 Rest of the South and Central America: Lyophilized Injectable Market Revenue and Forecast To 2028, By End User (US$ Million)
  • 11.5 Middle East & Africa Lyophilized Injectable Market Revenue and Forecasts To 2028
    • 11.5.1 Overview
    • 11.5.2 Middle East and Africa: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ 'Million)
    • 11.5.3 Middle East and Africa: Lyophilized Injectable Market, by Type of Packaging, 2019-2028 (US$ 'Million)
    • 11.5.4 Middle East and Africa: Lyophilized Injectable Market, by Type of Delivery, 2019-2028 (US$ 'Million)
    • 11.5.5 Middle East and Africa: Lyophilized Injectable Market, by Indication, 2019-2028 (US$ 'Million)
    • 11.5.6 Middle East and Africa: Lyophilized Injectable Market, by End User, 2019-2028 (US$ 'Million)
    • 11.5.7 Middle East and Africa: Lyophilized Injectable Market, by Country, 2021 & 2028 (%)
      • 11.5.7.1 South Africa: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ 'Million)
        • 11.5.7.1.1 Overview
        • 11.5.7.1.2 South Africa: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ 'Million)
        • 11.5.7.1.3 South Africa: Lyophilized Injectable Market, by Type Of Packaging, 2019-2028 (US$ 'Million)
        • 11.5.7.1.4 South Africa: Lyophilized Injectable Market, by Type Of Delivery, 2019-2028 (US$ 'Million)
        • 11.5.7.1.5 South Africa: Lyophilized Injectable Market, by Indication, 2019-2028 (US$ 'Million)
        • 11.5.7.1.6 South Africa: Lyophilized Injectable Market, by End User, 2019-2028 (US$ 'Million)
      • 11.5.7.2 Saudi Arabia: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ 'Million)
        • 11.5.7.2.1 Overview
        • 11.5.7.2.2 Saudi Arabia: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ 'Million)
        • 11.5.7.2.3 Saudi Arabia: Lyophilized Injectable Market, by Type Of Packaging, 2019-2028 (US$ 'Million)
        • 11.5.7.2.4 Saudi Arabia: Lyophilized Injectable Market, by Type Of Delivery, 2019-2028 (US$ 'Million)
        • 11.5.7.2.5 Saudi Arabia: Lyophilized Injectable Market, by Indication, 2019-2028 (US$ 'Million)
        • 11.5.7.2.6 Saudi Arabia: Lyophilized Injectable Market, by End User, 2019-2028 (US$ 'Million)
      • 11.5.7.3 UAE: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ 'Million)
        • 11.5.7.3.1 Overview
        • 11.5.7.3.2 UAE: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ 'Million)
        • 11.5.7.3.3 Rest of Middle East and Africa: Lyophilized Injectable Market, by Type Of Packaging, 2019-2028 (US$ 'Million)
        • 11.5.7.3.4 Rest of Middle East and Africa: Lyophilized Injectable Market, by Type Of Delivery, 2019-2028 (US$ 'Million)
        • 11.5.7.3.5 Rest of Middle East and Africa: Lyophilized Injectable Market, by Indication, 2019-2028 (US$ 'Million)
        • 11.5.7.3.6 Rest of Middle East and Africa: Lyophilized Injectable Market, by End User, 2019-2028 (US$ 'Million)
      • 11.5.7.4 Rest of Middle East and Africa: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ 'Million)
        • 11.5.7.4.1 Overview
        • 11.5.7.4.2 Rest of Middle East and Africa: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ 'Million)
        • 11.5.7.4.3 Rest of Middle East and Africa: Lyophilized Injectable Market, by Type Of Packaging, 2019-2028 (US$ 'Million)
        • 11.5.7.4.4 Rest of Middle East and Africa: Lyophilized Injectable Market, by Type Of Delivery, 2019-2028 (US$ 'Million)
        • 11.5.7.4.5 Rest of Middle East and Africa: Lyophilized Injectable Market, by Indication, 2019-2028 (US$ 'Million)
        • 11.5.7.4.6 Rest of Middle East and Africa: Lyophilized Injectable Market, by End User, 2019-2028 (US$ 'Million)

12. Impact of COVID-19 Pandemic on Global Lyophilized Injectable Market

  • 12.1 North America: Impact Assessment of COVID-19 Pandemic
  • 12.2 Europe: Impact Assessment of COVID-19 Pandemic
  • 12.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
  • 12.4 South and Central America: Impact Assessment of COVID-19 Pandemic
  • 12.5 Middle East and Africa: Impact Assessment of COVID-19 Pandemic

13. Lyophilized Injectable Market-Industry Landscape

  • 13.1 Overview
  • 13.2 Growth Strategies in the Lyophilized Injectable Market
  • 13.3 Inorganic Growth Strategies
    • 13.3.1 Overview
  • 13.4 Organic Growth Strategies
    • 13.4.1 Overview

14. Company Profiles

  • 14.1 Baxter
    • 14.1.1 Key Facts
    • 14.1.2 Business Description
    • 14.1.3 Products and Services
    • 14.1.4 Financial Overview
    • 14.1.5 SWOT Analysis
    • 14.1.6 Key Developments
  • 14.2 Nipro
    • 14.2.1 Key Facts
    • 14.2.2 Business Description
    • 14.2.3 Products and Services
    • 14.2.4 Financial Overview
    • 14.2.5 SWOT Analysis
    • 14.2.6 Key Developments
  • 14.3 Curia Global, Inc.
    • 14.3.1 Key Facts
    • 14.3.2 Business Description
    • 14.3.3 Products and Services
    • 14.3.4 Financial Overview
    • 14.3.5 SWOT Analysis
    • 14.3.6 Key Developments
  • 14.4 Recipharm AB
    • 14.4.1 Key Facts
    • 14.4.2 Business Description
    • 14.4.3 Products and Services
    • 14.4.4 Financial Overview
    • 14.4.5 SWOT Analysis
    • 14.4.6 Key Developments
  • 14.5 Vetter Pharma
    • 14.5.1 Key Facts
    • 14.5.2 Business Description
    • 14.5.3 Products and Services
    • 14.5.4 Financial Overview
    • 14.5.5 SWOT Analysis
    • 14.5.6 Key Developments
  • 14.6 Jubilant HollisterStier (Jubilant Pharma Limited)
    • 14.6.1 Key Facts
    • 14.6.2 Business Description
    • 14.6.3 Products and Services
    • 14.6.4 Financial Overview
    • 14.6.5 SWOT Analysis
    • 14.6.6 Key Developments
  • 14.7 Aristopharma Ltd.
    • 14.7.1 Key Facts
    • 14.7.2 Business Description
    • 14.7.3 Products and Services
    • 14.7.4 Financial Overview
    • 14.7.5 SWOT Analysis
    • 14.7.6 Key Developments
  • 14.8 CordenPharma International
    • 14.8.1 Key Facts
    • 14.8.2 Business Description
    • 14.8.3 Products and Services
    • 14.8.4 Financial Overview
    • 14.8.5 SWOT Analysis
    • 14.8.6 Key Developments
  • 14.9 Credence MedSystems, Inc.
    • 14.9.1 Key Facts
    • 14.9.2 Business Description
    • 14.9.3 Products and Services
    • 14.9.4 Financial Overview
    • 14.9.5 SWOT Analysis
    • 14.9.6 Key Developments
  • 14.10 S.G. Biopharm Pvt. Ltd.
    • 14.10.1 Key Facts
    • 14.10.2 Business Description
    • 14.10.3 Products and Services
    • 14.10.4 Financial Overview
    • 14.10.5 SWOT Analysis
    • 14.10.6 Key Developments

15. Appendix

  • 15.1 About The Insight Partners
  • 15.2 Glossary of Terms

List Of Tables

  • Table 1. Top 3 Lyophilized Drug Products ((Global Average Selling Price (ASP)) (2021)
  • Table 2. North America Lyophilized Injectable Market, by Type of Packaging - Revenue and Forecast to 2028 (US$ Million)
  • Table 3. North America: Lyophilized Injectable Market, by Type of Delivery - Revenue and Forecast to 2028 (US$ Million)
  • Table 4. North America: Lyophilized Injectable Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
  • Table 5. North America: Lyophilized Injectable Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 6. US Lyophilized Injectable Market, by Type of Packaging - Revenue and Forecast to 2028 (US$ Million)
  • Table 7. US Lyophilized Injectable Market, by Type of Delivery - Revenue and Forecast to 2028 (US$ Million)
  • Table 8. US Lyophilized Injectable Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
  • Table 9. US Lyophilized Injectable Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 10. Canada: Lyophilized Injectable Market, by Type of Packaging - Revenue and Forecast to 2028 (US$ Million)
  • Table 11. Canada: Lyophilized Injectable Market, by Type of Delivery - Revenue and Forecast to 2028 (US$ Million)
  • Table 12. Canada: Lyophilized Injectable Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
  • Table 13. Canada: Lyophilized Injectable Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 14. Mexico: Lyophilized Injectable Market, by Type of Packaging - Revenue and Forecast to 2028 (US$ Million)
  • Table 15. Mexico: Lyophilized Injectable Market, by Type of Delivery - Revenue and Forecast to 2028 (US$ Million)
  • Table 16. Mexico: Lyophilized Injectable Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
  • Table 17. Mexico: Lyophilized Injectable Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 18. Europe: Lyophilized Injectable Market, by Type Of Packaging - Revenue and Forecast to 2028 (US$ 'Million)
  • Table 19. Europe: Lyophilized Injectable Market, by Type Of Delivery - Revenue and Forecast to 2028 (US$ 'Million)
  • Table 20. Europe: Lyophilized Injectable Market, by Indication - Revenue and Forecast to 2028 (US$ 'Million)
  • Table 21. Europe: Lyophilized Injectable Market, by End User - Revenue and Forecast to 2028 (US$ 'Million)
  • Table 22. Germany: Lyophilized Injectable Market, by Type of Packaging - Revenue and Forecast to 2028 (US$ 'Million)
  • Table 23. Germany: Lyophilized Injectable Market, by Type of Delivery - Revenue and Forecast to 2028 (US$ 'Million)
  • Table 24. Germany: Lyophilized Injectable Market, by Indication - Revenue and Forecast to 2028 (US$ 'Million)
  • Table 25. Germany: Lyophilized Injectable Market, by End User - Revenue and Forecast to 2028 (US$ 'Million)
  • Table 26. UK: Lyophilized Injectable Market, by Type of Packaging - Revenue and Forecast to 2028 (US$ 'Million)
  • Table 27. UK: Lyophilized Injectable Market, by Type of Delivery - Revenue and Forecast to 2028 (US$ 'Million)
  • Table 28. UK: Lyophilized Injectable Market, by Indication - Revenue and Forecast to 2028 (US$ 'Million)
  • Table 29. UK: Lyophilized Injectable Market, by End User - Revenue and Forecast to 2028 (US$ 'Million)
  • Table 30. France: Lyophilized Injectable Market, by Type of Packaging - Revenue and Forecast to 2028 (US$ 'Million)
  • Table 31. France: Lyophilized Injectable Market, by Type of Delivery - Revenue and Forecast to 2028 (US$ 'Million)
  • Table 32. France: Lyophilized Injectable Market, by Indication - Revenue and Forecast to 2028 (US$ 'Million)
  • Table 33. France: Lyophilized Injectable Market, by End User - Revenue and Forecast to 2028 (US$ 'Million)
  • Table 34. Italy: Lyophilized Injectable Market, by Type of Packaging - Revenue and Forecast to 2028 (US$ 'Million)
  • Table 35. Italy: Lyophilized Injectable Market, by Type of Delivery - Revenue and Forecast to 2028 (US$ 'Million)
  • Table 36. Italy: Lyophilized Injectable Market, by Indication - Revenue and Forecast to 2028 (US$ 'Million)
  • Table 37. Italy: Lyophilized Injectable Market, by End User - Revenue and Forecast to 2028 (US$ 'Million)
  • Table 38. Spain: Lyophilized Injectable Market, by Type of Packaging - Revenue and Forecast to 2028 (US$ 'Million)
  • Table 39. Spain: Lyophilized Injectable Market, by Type of Delivery - Revenue and Forecast to 2028 (US$ 'Million)
  • Table 40. Spain: Lyophilized Injectable Market, by Indication - Revenue and Forecast to 2028 (US$ 'Million)
  • Table 41. Spain: Lyophilized Injectable Market, by End User - Revenue and Forecast to 2028 (US$ 'Million)
  • Table 42. Rest of Europe: Lyophilized Injectable Market, by Type of Packaging - Revenue and Forecast to 2028 (US$ 'Million)
  • Table 43. Rest of Europe: Lyophilized Injectable Market, by Type of Delivery - Revenue and Forecast to 2028 (US$ 'Million)
  • Table 44. Rest of Europe: Lyophilized Injectable Market, by Indication - Revenue and Forecast to 2028 (US$ 'Million)
  • Table 45. Rest of Europe: Lyophilized Injectable Market, by End User - Revenue and Forecast to 2028 (US$ 'Million)
  • Table 46. Asia Pacific: Lyophilized Injectable Market Revenue and Forecasts to 2028, By Type of Packaging (US$ Million).
  • Table 47. Asia Pacific: Lyophilized Injectable Market, by Type of Delivery - Revenue and Forecast to 2028 (US$ Million)
  • Table 48. Asia Pacific: Lyophilized Injectable Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
  • Table 49. Asia Pacific: Lyophilized Injectable Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 50. China: Lyophilized Injectable Market Revenue and Forecasts to 2028, By Type of Packaging (US$ Million)
  • Table 51. China: Lyophilized Injectable Market, by Type of Delivery - Revenue and Forecast to 2028 (US$ Million)
  • Table 52. China: Lyophilized Injectable Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
  • Table 53. China: Lyophilized Injectable Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 54. India: Lyophilized Injectable Market Revenue and Forecasts to 2028, By Type of Packaging (US$ Million)
  • Table 55. India: Lyophilized Injectable Market, by Type of Delivery - Revenue and Forecast to 2028 (US$ Million)
  • Table 56. India: Lyophilized Injectable Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
  • Table 57. India: Lyophilized Injectable Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 58. Japan: Lyophilized Injectable Market Revenue and Forecasts to 2028, By Type of Packaging (US$ Million)
  • Table 59. Japan: Lyophilized Injectable Market, by Type of Delivery- Revenue and Forecast to 2028 (US$ Million)
  • Table 60. Japan: Lyophilized Injectable Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
  • Table 61. Japan: Lyophilized Injectable Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 62. South Korea: Lyophilized Injectable Market Revenue and Forecasts to 2028, By Type of Packaging (US$ Million)
  • Table 63. South Korea: Lyophilized Injectable Market, by Type of Delivery - Revenue and Forecast to 2028 (US$ Million)
  • Table 64. South Korea: Lyophilized Injectable Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
  • Table 65. South Korea: Lyophilized Injectable Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 66. Australia: Lyophilized Injectable Market Revenue and Forecasts to 2028, By Type of Packaging (US$ Million)
  • Table 67. Australia: Lyophilized Injectable Market, by Type of Delivery - Revenue and Forecast to 2028 (US$ Million)
  • Table 68. Australia: Lyophilized Injectable Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
  • Table 69. Australia: Lyophilized Injectable Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 70. Rest of Asia Pacific: Lyophilized Injectable Market Revenue and Forecasts to 2028, By Type of Packaging (US$ Million)
  • Table 71. Rest of Asia Pacific: Lyophilized Injectable Market, by Type of Delivery - Revenue and Forecast to 2028 (US$ Million)
  • Table 72. Rest of Asia Pacific: Lyophilized Injectable Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
  • Table 73. Rest of Asia Pacific: Lyophilized Injectable Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 74. South and Central America: Lyophilized Injectable Market Revenue and Forecast to 2028, by Type of Packaging (US$ Million)
  • Table 75. South and Central America: Lyophilized Injectable Market Revenue and Forecast to 2028, by Type of Delivery (US$ Million)
  • Table 76. South and Central America: Lyophilized Injectable Market Revenue and Forecast to 2028, by Indication (US$ Million)
  • Table 77. South and Central America: Lyophilized Injectable Market Revenue and Forecast to 2028, by End User (US$ Million)
  • Table 78. Brazil: Lyophilized Injectable Market Revenue and Forecast to 2028, By Type of Packaging (US$ Million)
  • Table 79. Brazil: Lyophilized Injectable Market Revenue and Forecast to 2028, By Type of Delivery (US$ Million)
  • Table 80. Brazil: Lyophilized Injectable Market Revenue and Forecast to 2028, By Indication (US$ Million)
  • Table 81. Brazil: Lyophilized Injectable Market Revenue and Forecast to 2028, By End User (US$ Million)
  • Table 82. Argentina: Lyophilized Injectable Market Revenue and Forecast to 2028, By Type of Packaging (US$ Million)
  • Table 83. Argentina: Lyophilized Injectable Market Revenue and Forecast to 2028, By Type of Delivery (US$ Million)
  • Table 84. Argentina: Lyophilized Injectable Market Revenue and Forecast to 2028, By Indication (US$ Million)
  • Table 85. Argentina: Lyophilized Injectable Market Revenue and Forecast to 2028, By End User (US$ Million)
  • Table 86. Rest of the South and Central America: Lyophilized Injectable Market Revenue and Forecast to 2028, By Type of Packaging (US$ Million)
  • Table 87. Rest of the South and Central America: Lyophilized Injectable Market Revenue and Forecast to 2028, By Type of Delivery (US$ Million)
  • Table 88. Rest of the South and Central America: Lyophilized Injectable Market Revenue and Forecast to 2028, By Indication (US$ Million)
  • Table 89. Rest of the South and Central America: Lyophilized Injectable Market Revenue and Forecast to 2028, By End User (US$ Million)
  • Table 90. Middle East and Africa: Lyophilized Injectable Market, by Type of Packaging - Revenue and Forecast to 2028 (US$ 'Million)
  • Table 91. Middle East and Africa: Lyophilized Injectable Market, by Type of Delivery - Revenue and Forecast to 2028 (US$ 'Million)
  • Table 92. Middle East and Africa: Lyophilized Injectable Market, by Indication - Revenue and Forecast to 2028 (US$ 'Million)
  • Table 93. Middle East and Africa: Lyophilized Injectable Market, by End User - Revenue and Forecast to 2028 (US$ 'Million)
  • Table 94. South Africa: Lyophilized Injectable Market, by Type Of Packaging - Revenue and Forecast to 2028 ( US$ 'Million)
  • Table 95. South Africa: Lyophilized Injectable Market, by Type Of Delivery - Revenue and Forecast to 2028 (US$ 'Million)
  • Table 96. South Africa: Lyophilized Injectable Market, by Indication - Revenue and Forecast to 2028 (US$ 'Million)
  • Table 97. South Africa: Lyophilized Injectable Market, by End User - Revenue and Forecast to 2028 (US$ 'Million)
  • Table 98. Saudi Arabia: Lyophilized Injectable Market, by Type Of Packaging - Revenue and Forecast to 2028 (US$ 'Million)
  • Table 99. Saudi Arabia: Lyophilized Injectable Market, by Type Of Delivery - Revenue and Forecast to 2028 (US$ 'Million)
  • Table 100. Saudi Arabia: Lyophilized Injectable Market, by Indication - Revenue and Forecast to 2028 (US$ 'Million)
  • Table 101. Rest of Middle East and Africa: Lyophilized Injectable Market, by End User - Revenue and Forecast to 2028 (US$ 'Million)
  • Table 102. Rest of Middle East and Africa: Lyophilized Injectable Market, by Type Of Packaging - Revenue and Forecast to 2028 (US$ 'Million)
  • Table 103. Rest of Middle East and Africa: Lyophilized Injectable Market, by Type Of Delivery - Revenue and Forecast to 2028 (US$ 'Million)
  • Table 104. Rest of Middle East and Africa: Lyophilized Injectable Market, by Indication - Revenue and Forecast to 2028 (US$ 'Million)
  • Table 105. Rest of Middle East and Africa: Lyophilized Injectable Market, by End User - Revenue and Forecast to 2028 (US$ 'Million)
  • Table 106. Rest of Middle East and Africa: Lyophilized Injectable Market, by Type Of Packaging - Revenue and Forecast to 2028 (US$ 'Million)
  • Table 107. Rest of Middle East and Africa: Lyophilized Injectable Market, by Type Of Delivery - Revenue and Forecast to 2028 (US$ 'Million)
  • Table 108. Rest of Middle East and Africa: Lyophilized Injectable Market, by Indication - Revenue and Forecast to 2028 (US$ 'Million)
  • Table 109. Rest of Middle East and Africa: Lyophilized Injectable Market, by End User - Revenue and Forecast to 2028 (US$ 'Million)
  • Table 110. Recent Inorganic Growth Strategies in the Lyophilized Injectable Market
  • Table 111. Recent Organic Growth Strategies in the Lyophilized Injectable Market
  • Table 112. Glossary of Terms, Lyophilized Injectable Market

List Of Figures

  • Figure 1. Lyophilized Injectable Market Segmentation
  • Figure 2. Lyophilized Injectable Market - By Geography
  • Figure 3. Lyophilized Injectable Market Overview
  • Figure 4. Single-Use Vials Segment Held Largest Share by Type of Packaging in Lyophilized Injectable Market
  • Figure 5. Asia Pacific to Show Significant Growth During Forecast Period
  • Figure 6. Lyophilized Injectable Market, by Geography (US$ Million)
  • Figure 7. Global Lyophilized Injectable Market - Leading Country Markets (US$ Million)
  • Figure 8. Global Lyophilized Injectable Market, Industry Landscape
  • Figure 9. North America: PEST Analysis
  • Figure 10. Europe: PEST Analysis
  • Figure 11. Asia Pacific: PEST Analysis
  • Figure 12. Middle East and Africa: PEST Analysis
  • Figure 13. South and Central America: PEST Analysis
  • Figure 14. Experts Opinion
  • Figure 15. Lyophilized Injectable Market Impact Analysis of Drivers and Restraints
  • Figure 16. Global Lyophilized Injectable Market- Revenue Forecast and Analysis - 2020- 2028
  • Figure 17. Global Lyophilized Injectable Market- Revenue Forecast And Analysis - 2022 - 2028
  • Figure 18. Global Lyophilized Injectable Market - Market Potential Analysis, by Region
  • Figure 19. Global Lyophilized Injectable Market - Comparative Company Analysis
  • Figure 20. Global Lyophilized Injectable Market - Growth Strategy Analysis
  • Figure 21. Market Positioning Analysis of Key Players in Global Lyophilized Injectable Market
  • Figure 22. Market Share Analysis of Key Players in Global Lyophilized Injectable Market
  • Figure 23. Lyophilized Injectable Market Revenue Share, by Type of Packaging (2021 and 2028)
  • Figure 24. Single-use vials: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 25. Point-of-Care Reconstitution: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 26. Specialty Packaging: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 27. Lyophilized Injectable Market Revenue Share, by Type of Delivery (2021 and 2028)
  • Figure 28. Prefilled Diluent Syringes: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 29. Single Step Devices: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 30. Proprietary Reconstitution Devices: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 31. Multi-Step Devices: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 32. Lyophilized Injectable Market Revenue Share, by Indication (2021 and 2028)
  • Figure 33. Metabolic and Oncology Conditions: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 34. Infectious Diseases: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 35. Autoimmune Diseases: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 36. Other Indications: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 37. Lyophilized Injectable Market, by End User, 2021 and 2028 (%)
  • Figure 38. Hospitals: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 39. Ambulatory Surgical Centers: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 40. Specialty Clinics: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 41. Other End Users: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 42. North America: Lyophilized Injectable Market, by Key Country - Revenue (2021) (US$ Million)
  • Figure 43. North America Lyophilized Injectable Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 44. North America: Lyophilized Injectable Market, by Country, 2021 & 2028 (%)
  • Figure 45. US: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 46. Canada: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 47. Mexico: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 48. Europe: Lyophilized Injectable Market, by Key Country - Revenue (2021) (US$ 'Million)
  • Figure 49. Europe: Lyophilized Injectable Market Revenue and Forecast to 2028 (US$ 'Million)
  • Figure 50. Europe: Lyophilized Injectable Market, by Country, 2021 & 2028 (%)
  • Figure 51. Germany: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ 'Million)
  • Figure 52. UK: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ 'Million)
  • Figure 53. France: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ 'Million)
  • Figure 54. Italy: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ 'Million)
  • Figure 55. Spain: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ 'Million)
  • Figure 56. Rest of Europe: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ 'Million)
  • Figure 57. Asia Pacific Lyophilized Injectable Market Overview, by Country (2021)
  • Figure 58. Asia Pacific: Lyophilized Injectable Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 59. Asia Pacific: Lyophilized Injectable Market, by Country, 2021 & 2028 (%)
  • Figure 60. China: Lyophilized Injectable Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 61. India: Lyophilized Injectable Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 62. Japan: Lyophilized Injectable Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 63. South Korea: Lyophilized Injectable Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 64. Australia: Lyophilized Injectable Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 65. Rest of Asia Pacific: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 66. South and Central America Lyophilized Injectable Market Revenue Overview, by Country, 2021 (US$ Million)
  • Figure 67. South and Central America Lyophilized Injectable Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 68. South and Central America: Lyophilized Injectable Market, by Country, 2021 & 2028 (%)
  • Figure 69. Brazil: Lyophilized Injectable Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 70. Argentina: Lyophilized Injectable Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 71. Rest of the South and Central America: Lyophilized Injectable Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 72. Middle East and Africa: Lyophilized Injectable Market, by Key Country - Revenue (2021) (US$ 'Million)
  • Figure 73. Middle East and Africa: Lyophilized Injectable Market Revenue and Forecast to 2028 (US$ 'Million)
  • Figure 74. Middle East and Africa: Lyophilized Injectable Market, by Country, 2021 & 2028 (%)
  • Figure 75. South Africa: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ 'Million)
  • Figure 76. Saudi Arabia: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ 'Million)
  • Figure 77. UAE: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ 'Million)
  • Figure 78. Rest of Middle East and Africa: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ 'Million)
  • Figure 79. Impact of COVID-19 Pandemic in North American Country Markets
  • Figure 80. Impact Of COVID-19 Pandemic in Europe Country Markets
  • Figure 81. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
  • Figure 82. Impact of COVID-19 Pandemic in South and Central American Countries
  • Figure 83. Impact Of COVID-19 Pandemic in Middle East & Africa Country Markets
  • Figure 84. Growth Strategies in the Lyophilized Injectable Market